$MRNA chickens not able to hold a panicky drop from $400s have lost, &now SHORT SELLING all the way to $300 turn to loose on covering into $400s! Same rout as in earlier days of $TSLA. This is one of the most promising biotech names in decades if not 21st century to date! #Moderna roadmap unfolding from single preventative, moving to combos and finally into REAL therapeutics on #mRna platform with 100s of millions!!! patients already! Just Unprecedented!